Isidro Salusky, MD
Pediatric Nephrology · Los Angeles, CANPI 1861501546
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,096 of the $47,309 with a category attached, or 63.6%. Ultragenyx Pharmaceutical Inc. accounts for 85.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $20,314 and has fallen 98.0% since, to $402 in 2025. Among pediatric nephrology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $639.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$40K
- Akebia Therapeutics Inc$5K
- Amgen$926
- Kyowa Kirin, Inc.$198
- Ardelyx, Inc.$144
- Fresenius USA Marketing, Inc.$81
- plus $118 from 3 others
Across 70 payments — averaging $6652.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$377K
- Amgen$69K
- AbbVie$20K
What the payments were for
- Consulting fees$30,09664%
- Speaking & faculty fees$8,60018%
- Travel & lodging$6,36713%
- Food & beverage$2,2465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 47 | $40,400 |
| Akebia Therapeutics Inc | 5 | $5,443 |
| Amgen | 10 | $926 |
| Kyowa Kirin, Inc. | 6 | $198 |
| Ardelyx, Inc. | 1 | $144 |
| Fresenius USA Marketing, Inc. | 1 | $81 |
| Apellis Pharmaceuticals, Inc. | 2 | $62 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Novo Nordisk | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRYSVITA$33,868
- Cryvista$5,372
- AURYXIA$5,355
- XPHOZAH 30 MG$144
- Vafseo$123
How this compares
$47,309 in reported general payments places this provider in the 95th percentile of 75 pediatric nephrology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric nephrology in Los Angeles
- Ora YadinLos Angeles$42K
- Elaine KamilLos Angeles$18K
- Patricia WengLos Angeles$8K
- Rachana SrivastavaLos Angeles$7K
- Robert EttengerLos Angeles$3K
- Mohammad MalekzadehLos Angeles$149
- Elaine KuLos Angeles$123
- Ganga ChandraLos Angeles$122
- Paul GrimmPalo Alto$99K
- Shina MenonPalo Alto$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.